Does ATROPINE Cause Malignant neoplasm progression? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Malignant neoplasm progression have been filed in association with ATROPINE (Hepaticol Drops 5008). This represents 0.2% of all adverse event reports for ATROPINE.
6
Reports of Malignant neoplasm progression with ATROPINE
0.2%
of all ATROPINE reports
2
Deaths
2
Hospitalizations
How Dangerous Is Malignant neoplasm progression From ATROPINE?
Of the 6 reports, 2 (33.3%) resulted in death, 2 (33.3%) required hospitalization, and 1 (16.7%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ATROPINE. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does ATROPINE Cause?
Drug ineffective (572)
Off label use (289)
Toxicity to various agents (231)
Macular degeneration (221)
Hypotension (216)
Nausea (167)
Pain (166)
Bradycardia (150)
Constipation (146)
Pyrexia (141)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which ATROPINE Alternatives Have Lower Malignant neoplasm progression Risk?
ATROPINE vs ATROPINE\ATROPINE
ATROPINE vs ATROPINE\DIPHENOXYLATE
ATROPINE vs AUBAGIO
ATROPINE vs AUGMENTIN
ATROPINE vs AUTOLOGOUS CULTURED CHONDROCYTES